Funding will enable BDD to scale up GMP manufacture of revolutionary time controlled “pill within a pill”. Archangels, the Edinburgh-based business angel syndicate, the Scottish Investment Bank, the investment arm of Scotland’s enterprise agencies, and Bio-Images Drug Delivery Limited (BDD) announce the completion of a £2m...
Asynt reports that medicinal chemistry specialists Charnwood Molecular have been using the DrySyn MAXI heating system to successfully and reproducibly scale up syntheses within their contract research laboratories. Dr Michael McKenzie, Head of Operations, said: “Here at Charnwood Molecular our experienced preclinical R&D team routinely investigate...
A two-year-long discovery chemistry collaboration between Charnwood Molecular and Forendo Pharma has seen compounds move from discovery to pre-clinical development. Charnwood Molecular and Forendo Pharma have been collaborating since September 2015, with Charnwood Molecular synthesising challenging steroidal analogues of a hit compound initially identified at Forendo...
Upperton Pharma Solutions is pleased to announce that the company has relocated to larger, self-contained facilities at Highfields Science Park, adjacent to the University of Nottingham. The move to new premises underlines the company’s rapid expansion and will enable it to develop its own cGMP...
A recently formed Manchester health consortium, led by The Christie, has been awarded nearly £7 million of funding to ensure more patients benefit from a new generation of disease-fighting drugs for cancer and non-cancer illnesses. Manchester is one of only three centres in Britain awarded funding...
Aseptika and BioHub based, Zenzium, Ltd., have been awarded a grant from the UK’s innovation agency to develop a new home-based early warning system for people with severe respiratory disease. Artificial Intelligence (AI) will automatically analyse and learn from data generated by the patient at...
Nick Merryfield LLP (NMLLP), a private equity firm focused on the healthcare industry, announced today the formation of a pioneering market access organisation, the Verpora Group. Under an international agreement, the Verpora Group will help improve patient access to life-enhancing medicines through the integration of...
NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne. Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel treatments for diseases with unmet medical...
Staffordshire University are hosting a number of employer focused events. If you would like to find out more about Staffordshire University and our Apprenticeships click this link. New recruits and existing employees are eligible to be a higher or degree apprentice. Apprentices can study for a...
A unique technology for the construction industry offering immersive “walk throughs” of unbuilt houses; a novel method of recycling print toner powder for use across a range of applications including art, construction and animal medicines; and a technique for new drug discovery are among the...